Gliclazid retard Zentiva 30 mg, Retardtabletten - 120 Swissmedic Key 58740006 Registration Holder Helvepharm AG Name Gliclazid retard Zentiva 30 mg, Retardtabletten Date of registration 15.10.2008 Original/Generic Generic Introduction of Sequence 15.10.2008 ATC-Classification Gliclazide (A10BB09) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.06.20. Show package size 120 Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 10.66 Limitation Yes Limitation text
Deductible 10 % Consumer price 28.10 Feedback FB Daily cost GTIN 7680587400061 Medication Code Synthetika Pharmacode Disponibility
Composition gliclazidum 30 mg, hypromellosum, calcii carbonas, lactosum monohydricum 73.5 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Gliclazide 30 mg
BAG: Active Agent Dose Gliclazide 30 mg
Inactive agents Dose Calcium Carbonate Hypromellosum Lactose Monohydrate 73.5 mg Magnesii Stearas Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 17.12.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
